Miranda, Marissa C.

HRN: 22-07-18  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/17/2022
CEFTAZIDIME 1GM (VIAL)
10/17/2022
10/23/2022
IV
2grams
Q8hrs
Sepsis Probably Secondary To HAP
Waiting Final Action 

Indication:  Empirical Escalation    Type of Infection:  PneumoniaUnspecified Sepsis    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: